Recognizing the potential of semaglutide for weight management, researchers developed Wegovy, a higher-dose version of semaglutide approved in 2021 explicitly for chronic weight management in patients with obesity or overweight with at least one weight-related comorbidity
The injection site should be free of bruises, scars, moles, or any skin irritation, and you should rotate sites at least 1 inch apart with each injection
A clinical assessment to determine whether Semaglutide, Tirzepatide, or another GLP-1 medication is right for your body, your health history, and your weight loss goals
5 These guidelines align with the American Diabetes Association (ADA) standards of care which also provide strong recommendations based on robust clinical trial data supporting the cardiovascular benefits of GLP-1 RAs, particularly in patients with established cardiovascular disease and chronic kidney disease (CKD)
Never stop or change medication without consulting your healthcare provider
That is why nutrient-dense meals and targeted supplementation can be helpful
